Nervgen Pharma Corp Stock Market Value

NGENF Stock  USD 1.89  0.01  0.53%   
NervGen Pharma's market value is the price at which a share of NervGen Pharma trades on a public exchange. It measures the collective expectations of NervGen Pharma Corp investors about its performance. NervGen Pharma is trading at 1.89 as of the 15th of March 2025. This is a 0.53% down since the beginning of the trading day. The stock's lowest day price was 1.88.
With this module, you can estimate the performance of a buy and hold strategy of NervGen Pharma Corp and determine expected loss or profit from investing in NervGen Pharma over a given investment horizon. Check out NervGen Pharma Correlation, NervGen Pharma Volatility and NervGen Pharma Alpha and Beta module to complement your research on NervGen Pharma.
Symbol

Please note, there is a significant difference between NervGen Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if NervGen Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NervGen Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

NervGen Pharma 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to NervGen Pharma's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of NervGen Pharma.
0.00
12/15/2024
No Change 0.00  0.0 
In 3 months and 1 day
03/15/2025
0.00
If you would invest  0.00  in NervGen Pharma on December 15, 2024 and sell it all today you would earn a total of 0.00 from holding NervGen Pharma Corp or generate 0.0% return on investment in NervGen Pharma over 90 days. NervGen Pharma is related to or competes with Space Communication, Radcom, Tesla, Cardinal Health, Sea, Zhihu, and MYT Netherlands. NervGen Pharma Corp., together with its subsidiaries, engages in the discovery, development, and commercialization of ph... More

NervGen Pharma Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure NervGen Pharma's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess NervGen Pharma Corp upside and downside potential and time the market with a certain degree of confidence.

NervGen Pharma Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for NervGen Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as NervGen Pharma's standard deviation. In reality, there are many statistical measures that can use NervGen Pharma historical prices to predict the future NervGen Pharma's volatility.
Hype
Prediction
LowEstimatedHigh
0.091.896.25
Details
Intrinsic
Valuation
LowRealHigh
0.081.646.00
Details
Naive
Forecast
LowNextHigh
0.041.956.31
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.832.012.19
Details

NervGen Pharma Corp Backtested Returns

At this point, NervGen Pharma is dangerous. NervGen Pharma Corp has Sharpe Ratio of close to zero, which conveys that the firm had a close to zero % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for NervGen Pharma, which you can use to evaluate the volatility of the firm. Please verify NervGen Pharma's Mean Deviation of 2.38, risk adjusted performance of 0.0172, and Downside Deviation of 3.02 to check out if the risk estimate we provide is consistent with the expected return of 0.0086%. The company secures a Beta (Market Risk) of -0.37, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning NervGen Pharma are expected to decrease at a much lower rate. During the bear market, NervGen Pharma is likely to outperform the market. NervGen Pharma Corp right now secures a risk of 4.36%. Please verify NervGen Pharma Corp expected short fall, and the relationship between the value at risk and daily balance of power , to decide if NervGen Pharma Corp will be following its current price movements.

Auto-correlation

    
  0.62  

Good predictability

NervGen Pharma Corp has good predictability. Overlapping area represents the amount of predictability between NervGen Pharma time series from 15th of December 2024 to 29th of January 2025 and 29th of January 2025 to 15th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of NervGen Pharma Corp price movement. The serial correlation of 0.62 indicates that roughly 62.0% of current NervGen Pharma price fluctuation can be explain by its past prices.
Correlation Coefficient0.62
Spearman Rank Test0.26
Residual Average0.0
Price Variance0.01

NervGen Pharma Corp lagged returns against current returns

Autocorrelation, which is NervGen Pharma otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting NervGen Pharma's otc stock expected returns. We can calculate the autocorrelation of NervGen Pharma returns to help us make a trade decision. For example, suppose you find that NervGen Pharma has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

NervGen Pharma regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If NervGen Pharma otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if NervGen Pharma otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in NervGen Pharma otc stock over time.
   Current vs Lagged Prices   
       Timeline  

NervGen Pharma Lagged Returns

When evaluating NervGen Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of NervGen Pharma otc stock have on its future price. NervGen Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, NervGen Pharma autocorrelation shows the relationship between NervGen Pharma otc stock current value and its past values and can show if there is a momentum factor associated with investing in NervGen Pharma Corp.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in NervGen OTC Stock

NervGen Pharma financial ratios help investors to determine whether NervGen OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NervGen with respect to the benefits of owning NervGen Pharma security.